Virbac
Virbac is French animal health company. Founded in 1968. Approximately 4,350 employees. (Wikidata)
Virbac's strongest tracked position is the Pet Pathogen Detection Kits Market at an estimated 6.5% share in a market growing at 6.8% CAGR. Average estimated share across all tracked markets is 6.8%, indicating a meaningful incumbent presence.
Meridian Consensus tracks Virbac in 2 markets across 2 industries (healthcare, Healthcare). Estimated in-market revenue is $264M, the sum of share × market size across appearances — a modeled figure, not reported company revenue.
Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology
Market positions
Avg share 6.8% · sorted by est. revenue| Market | CAGR | Share |
|---|---|---|
| Pet Pathogen Detection Kits Market | 6.8% | 6.5% |
| Veterinary Urinalysis Market | 5.0% | 7.0% |
Meridian Dossier
Need diligence-grade depth on Virbac?
Commission a source-cited diligence dossier on Virbac: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.
Virbac: frequently asked
Meridian Consensus tracks Virbac in 2 markets: Pet Pathogen Detection Kits Market ($2.9B), Veterinary Urinalysis Market ($1.1B), spanning healthcare, Healthcare.
Virbac's strongest tracked position is the Pet Pathogen Detection Kits Market, a $2.9B market growing at 6.8% CAGR, where it holds an estimated 6.5% share as of June 2026.
Across Meridian-tracked markets, Virbac's closest peers are IDEXX Laboratories, Zoetis, Antech Diagnostics, Neogen Corporation, bioMérieux, with the largest overlap in the Pet Pathogen Detection Kits Market. Peer mapping is based on co-appearance in the same tracked markets.
No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.
Adjacent markets in healthcare · Healthcare
Tracked markets in the same industries where Virbac is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.
Operators that compete with Virbac
Virbac's closest peers across Meridian-tracked markets are IDEXX Laboratories, Zoetis, Antech Diagnostics, among others, ordered by how many tracked markets they share with the operator.
- 2 sharedIDEXX LaboratoriesTop overlap · Pet Pathogen Detection Kits
- 2 sharedZoetisTop overlap · Pet Pathogen Detection Kits
- 2 sharedAntech DiagnosticsTop overlap · Pet Pathogen Detection Kits
- 2 sharedNeogen CorporationTop overlap · Pet Pathogen Detection Kits
- 2 sharedbioMérieuxTop overlap · Pet Pathogen Detection Kits
- 2 sharedWoodley EquipmentTop overlap · Pet Pathogen Detection Kits
- 2 sharedHeska CorporationTop overlap · Pet Pathogen Detection Kits
- 2 sharedAbaxisTop overlap · Pet Pathogen Detection Kits
- 1 sharedThermo Fisher ScientificTop overlap · Pet Pathogen Detection Kits
- 1 sharedQiagenTop overlap · Pet Pathogen Detection Kits
Or browse the full A–Z operator directory for any company in the catalogue.
Meridian Consensus Digest
Free · WeeklyNot ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.